Our Story
OxyLo is a San Diego based Biotechnology company that is focused on helping pancreatic patients get their life back. Our patented HypoxyCaps are a revolutionary biomaterial based implant designed to actively remove oxygen and glucose from the inside of a tumor. Our Mission is to give hope and time back to patients who need it most.
We are a team of international PhD scientists with years of experience working closely to combine our expertise in biology, chemistry, and engineering. Our philosophy of focusing on creativity and interdisciplinary science has led to the breakthrough innovations that we aim to provide today.
Who We Are
Tom Molley, PhD Chief Executive Officer
& Co-founder
Kristopher Kilian, PhD Chief Scientific Advisor
& Co-founder
Gisselle Gonzalez, PhD VP of Research & Development